Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Development and Preliminary Application Evaluation of a Clinical Decision Support Training Platform for Dementia Care

14. september 2026 oppdatert av: Huei-Ling Huang, Chang Gung Memorial Hospital

This study consists of two phases: an observational phase and a single-arm interventional phase. In Phase 1, qualitative interviews will be conducted to explore the decision-making challenges faced by second-year students in a two-year undergraduate program who are approaching graduation when providing care for people with dementia. In Phase 2, a single-arm intervention will be implemented using an interactive web-based digital clinical decision support training platform. The following research questions will be examined:

  1. Does the interactive web-based digital clinical decision support training platform significantly improve students' decision-making competency in providing assistance with activities of daily living for people with dementia?
  2. Does the interactive web-based digital clinical decision support training platform significantly improve students' judgment competency in managing behavioral problems associated with dementia?
  3. Does the interactive web-based digital clinical decision support training platform significantly improve students' competency in supporting family caregivers experiencing caregiving burden and in connecting them with appropriate resources?

Studieoversikt

Status

Har ikke rekruttert ennå

Studietype

Intervensjonell

Registrering (Antatt)

130

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Ja

Beskrivelse

Inclusion Criteria in Phase 1:

  1. Aged 20 years or older.
  2. Willing to provide written informed consent.
  3. Currently a second-year student in the Department of Gerontology and Health Care Management.
  4. Has prior practicum experience in geriatric care or practical experience in dementia care.
  5. Voluntarily agrees to participate in the study.

Inclusion Criteria in Phase 2:

  1. Aged 20 years or older.
  2. Willing to provide written informed consent.
  3. Currently a second-year student in the Department of Gerontology and Health Care Management.
  4. Has prior practicum experience in geriatric care or practical experience in dementia care.
  5. Voluntarily agrees to participate in the study.
  6. Able to operate the information platform. Exclusion Criteria in Phase 1 and 2: Students who have taken a leave of absence from school or who decline to provide informed consent to participate.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Helsetjenesteforskning
  • Tildeling: N/A
  • Intervensjonsmodell: Enkeltgruppeoppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: care decision support training group
The care decision support training group will receive an educational intervention using an interactive web-based digital care decision support training platform.
The participants will receive an educational intervention using an interactive web-based digital care decision support training platform. The training is centered on scenario-based modules and incorporates guidance on decision branches, situational judgment, and care plan development.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Dementia Care Professional Competency Assessment Scale
Tidsramme: Baseline and after completion of all training modules (up to 18 weeks)
  1. The Dementia Care Professional Competency Assessment Scale was developed in our previous research supported by the Taiwan Ministry of Science and Technology (Grant No. 106-2511-S-255-002-MY3) to assess dementia care competency among students.
  2. The original scale contains nine subscales with 74 items. In this study, three subscales comprising 33 items are used. Each item is rated on a 5-point Likert scale from 1 to 5, with higher scores indicating greater dementia care competency.
Baseline and after completion of all training modules (up to 18 weeks)

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Problem solving, Teamwork Competency Assessment Scale
Tidsramme: Baseline and after completion of all training modules (up to 18 weeks)
  1. The Dementia Care Professional Competency Assessment Scale was developed in our previous research supported by the Taiwan Ministry of Science and Technology (Grant No. 106-2511-S-255-002-MY3) to assess dementia care competency among students.
  2. The scale contains 22 items, including 10 items assessing problem-solving competency and 12 items assessing teamwork competency. Higher scores indicate greater problem-solving and teamwork competency.
Baseline and after completion of all training modules (up to 18 weeks)
Participants' Experiences and Feedback on the Training Program
Tidsramme: After completion of all training modules (up to 18 weeks)
Students will complete a feedback form to provide their perceptions and experiences regarding the interactive web-based care decision support training program. The form includes open-ended questions regarding their learning experiences, perceived usefulness of the training, difficulties encountered, and suggestions for improvement. Qualitative responses will be analyzed to explore participants' experiences and perspectives regarding the training program.
After completion of all training modules (up to 18 weeks)

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. oktober 2026

Primær fullføring (Antatt)

1. juni 2027

Studiet fullført (Antatt)

1. juli 2027

Datoer for studieregistrering

Først innsendt

9. september 2026

Først innsendt som oppfylte QC-kriteriene

14. september 2026

Først lagt ut (Faktiske)

16. september 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

16. september 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

14. september 2026

Sist bekreftet

1. september 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

There is currently no plan to share individual participant data from this study with other researchers. Participants may separately consent to the future use of their de-identified data for related research. Any such future use will be subject to applicable ethical review and the scope of the participant's consent.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere